skip to the content

Clinical Trials

HIV Treatment Study

An International, Multicenter, Prospective Observational Study of the Safety of Maraviroc Used with Optimized Background Therapy in Treatment-Experienced HIV-1 Infected Patients

Protocol ID

08-02-160

Protocol Description

Maraviroc is a drug that is approved for HIV-1 infected patients. In this study, the safety of maraviroc, its long-term effects on HIV infection, and how well people tolerate it will be evaluated.

Eligibility Criteria

Patients with HIV

Primary Investigator(s)

  • Joseph McGowan, MD

Contact Information

Ali Smith-Hannah
(516) 562-6389
asmith5@nshs.edu

Last Update

April 2, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Infectious Diseases:
top
top